A strong clinical discovery can lose its path to translation if intellectual property is not considered early enough. Knowing when, why and how to protect an idea is often the difference between a research project that stays in the lab and one that reaches patients. Featuring Prof Victoria Cogger (CEO, Sydney Biomedical Accelerator), Michael Powell […]